Literature DB >> 21516191

A Bayesian Shrinkage Model for Incomplete Longitudinal Binary Data with Application to the Breast Cancer Prevention Trial.

C Wang1, M J Daniels, D O Scharfstein, S Land.   

Abstract

We consider inference in randomized longitudinal studies with missing data that is generated by skipped clinic visits and loss to follow-up. In this setting, it is well known that full data estimands are not identified unless unverified assumptions are imposed. We assume a non-future dependence model for the drop-out mechanism and partial ignorability for the intermittent missingness. We posit an exponential tilt model that links non-identifiable distributions and distributions identified under partial ignorability. This exponential tilt model is indexed by non-identified parameters, which are assumed to have an informative prior distribution, elicited from subject-matter experts. Under this model, full data estimands are shown to be expressed as functionals of the distribution of the observed data. To avoid the curse of dimensionality, we model the distribution of the observed data using a Bayesian shrinkage model. In a simulation study, we compare our approach to a fully parametric and a fully saturated model for the distribution of the observed data. Our methodology is motivated by, and applied to, data from the Breast Cancer Prevention Trial.

Entities:  

Year:  2010        PMID: 21516191      PMCID: PMC3079242          DOI: 10.1198/jasa.2010.ap09321

Source DB:  PubMed          Journal:  J Am Stat Assoc        ISSN: 0162-1459            Impact factor:   5.033


  28 in total

1.  Strategies to fit pattern-mixture models.

Authors:  Herbert Thijs; Geert Molenberghs; Bart Michiels; Geert Verbeke; Desmond Curran
Journal:  Biostatistics       Date:  2002-06       Impact factor: 5.899

2.  Marginalized transition models for longitudinal binary data with ignorable and non-ignorable drop-out.

Authors:  Brenda F Kurland; Patrick J Heagerty
Journal:  Stat Med       Date:  2004-09-15       Impact factor: 2.373

3.  On the construction of bounds in prospective studies with missing ordinal outcomes: application to the good behavior game trial.

Authors:  Daniel O Scharfstein; Charles F Manski; James C Anthony
Journal:  Biometrics       Date:  2004-03       Impact factor: 2.571

4.  Modeling longitudinal data with nonignorable dropouts using a latent dropout class model.

Authors:  Jason Roy
Journal:  Biometrics       Date:  2003-12       Impact factor: 2.571

5.  Closed-form estimates for missing counts in two-way contingency tables.

Authors:  S G Baker; W F Rosenberger; R Dersimonian
Journal:  Stat Med       Date:  1992-03       Impact factor: 2.373

6.  On estimation of vaccine efficacy using validation samples with selection bias.

Authors:  Daniel O Scharfstein; M Elizabeth Halloran; Haitao Chu; Michael J Daniels
Journal:  Biostatistics       Date:  2006-03-23       Impact factor: 5.899

7.  A Bayesian sensitivity model for intention-to-treat analysis on binary outcomes with dropouts.

Authors:  Niko A Kaciroti; M Anthony Schork; Trivellore Raghunathan; Stevo Julius
Journal:  Stat Med       Date:  2009-02-15       Impact factor: 2.373

8.  Model-based approaches to analysing incomplete longitudinal and failure time data.

Authors:  J W Hogan; N M Laird
Journal:  Stat Med       Date:  1997 Jan 15-Feb 15       Impact factor: 2.373

9.  Mixture models for the joint distribution of repeated measures and event times.

Authors:  J W Hogan; N M Laird
Journal:  Stat Med       Date:  1997 Jan 15-Feb 15       Impact factor: 2.373

10.  Modelling progression of CD4-lymphocyte count and its relationship to survival time.

Authors:  V De Gruttola; X M Tu
Journal:  Biometrics       Date:  1994-12       Impact factor: 2.571

View more
  9 in total

1.  A Bayesian Vector Autoregressive Model with Nonignorable Missingness in Dependent Variables and Covariates: Development, Evaluation, and Application to Family Processes.

Authors:  Linying Ji; Meng Chen; Zita Oravecz; E Mark Cummings; Zhao-Hua Lu; Sy-Miin Chow
Journal:  Struct Equ Modeling       Date:  2020       Impact factor: 6.125

2.  A note on MAR, identifying restrictions, model comparison, and sensitivity analysis in pattern mixture models with and without covariates for incomplete data.

Authors:  Chenguang Wang; Michael J Daniels
Journal:  Biometrics       Date:  2011-03-01       Impact factor: 2.571

3.  Fully Bayesian inference under ignorable missingness in the presence of auxiliary covariates.

Authors:  M J Daniels; C Wang; B H Marcus
Journal:  Biometrics       Date:  2013-12-10       Impact factor: 2.571

4.  Sensitivity analysis for nonignorable missingness and outcome misclassification from proxy reports.

Authors:  Michelle Shardell; Eleanor M Simonsick; Gregory E Hicks; Barbara Resnick; Luigi Ferrucci; Jay Magaziner
Journal:  Epidemiology       Date:  2013-03       Impact factor: 4.822

5.  A Flexible Bayesian Approach to Monotone Missing Data in Longitudinal Studies with Nonignorable Missingness with Application to an Acute Schizophrenia Clinical Trial.

Authors:  Antonio R Linero; Michael J Daniels
Journal:  J Am Stat Assoc       Date:  2015-03       Impact factor: 5.033

6.  Bayesian methods for nonignorable dropout in joint models in smoking cessation studies.

Authors:  J T Gaskins; M J Daniels; B H Marcus
Journal:  J Am Stat Assoc       Date:  2017-01-05       Impact factor: 5.033

7.  Bayesian Approaches for Missing Not at Random Outcome Data: The Role of Identifying Restrictions.

Authors:  Antonio R Linero; Michael J Daniels
Journal:  Stat Sci       Date:  2018-05-03       Impact factor: 2.901

8.  A Semiparametric Bayesian Approach to Dropout in Longitudinal Studies with Auxiliary Covariates.

Authors:  Tianjian Zhou; Michael J Daniels; Peter Müller
Journal:  J Comput Graph Stat       Date:  2019-07-02       Impact factor: 2.302

9.  Applications of Bayesian shrinkage prior models in clinical research with categorical responses.

Authors:  Subhadip Pal; Riten Mitra; Arinjita Bhattacharyya; Shesh Rai
Journal:  BMC Med Res Methodol       Date:  2022-04-28       Impact factor: 4.612

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.